CAD 0.18
(-10.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -1.45 Million | -2.45 Million | -2.87 Million | -2.95 Million | -1.31 Million | -1.04 Million |
Net Income | -2.34 Million | -2.48 Million | -3.85 Million | -2.93 Million | -1.25 Million | -1.4 Million |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 542.01 Thousand | 1 Million | 1.83 Million | 1.35 Million | 192.17 Thousand | 115.54 Thousand |
Change in working capital | 85.41 Thousand | -972.38 Thousand | -848.81 Thousand | -1.41 Million | -234.91 Thousand | -121.23 Thousand |
Other non-cash items | 266.98 Thousand | -416.00 | -590.00 | 39.12 Thousand | -20.29 Thousand | 364.93 Thousand |
Investing Cash Flow | -5.38 Million | -6.61 Million | -6.58 Million | -4.85 Million | -1.62 Million | -1.59 Million |
Investments in PPE | -529.00 | -6.61 Million | -6.58 Million | -4.83 Million | -1.62 Million | -1.5 Million |
Acquisitions | - | - | - | - | - | -90.97 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -5.38 Million | - | - | -25 Thousand | - | -111.83 Thousand |
Financing Cash Flow | 2.54 Million | 1.85 Million | 411.27 Thousand | 28.07 Million | 3.38 Million | 2.65 Million |
Debt repayment | - | - | - | -1.31 Million | -229.42 Thousand | -58.78 Thousand |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | 2.54 Million | 1.85 Million | 411.27 Thousand | 30.81 Million | 3.5 Million | 2.06 Million |
Other Financing Activities | - | 1855.78 | 411.28 | -1.42 Million | 107.49 Thousand | 650.05 Thousand |
Accounts receivables | -331.38 Thousand | 25.89 Thousand | 49.81 Thousand | -49.1 Thousand | -6129.00 | 12.19 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 416.79 Thousand | -998.28 Thousand | -898.62 Thousand | -1.36 Million | -228.78 Thousand | -133.43 Thousand |
Cash at beginning of period | 4.56 Million | 11.78 Million | 20.83 Million | 569.03 Thousand | 129.81 Thousand | 118.62 Thousand |
Cash at end of period | 265.83 Thousand | 4.56 Million | 11.78 Million | 20.83 Million | 569.03 Thousand | 129.81 Thousand |
Capital Expenditure | -529.00 | -6.61 Million | -6.58 Million | -4.83 Million | -1.62 Million | -1.5 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -4.29 Million | -7.21 Million | -9.04 Million | 20.26 Million | 439.22 Thousand | 11.19 Thousand |
Free Cash Flow | -1.45 Million | -9.07 Million | -9.45 Million | -7.79 Million | -2.94 Million | -2.55 Million |
Breakdown | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -1.28 Million | -8336.00 | -823.05 Thousand | -237.39 Thousand | -2.48 Million | -489.98 Thousand |
Depreciation & Amortization | - | - | - | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | 869.84 Thousand | -546.39 Thousand | 109.27 Thousand | 109.27 Thousand | 1 Million | 170.68 Thousand |
Change in working capital | 565.88 Thousand | -816.65 Thousand | 317.06 Thousand | 19.11 Thousand | -972.38 Thousand | -119.17 Thousand |
Other non-cash items | 266.98 Thousand | -364.69 Thousand | 370.44 Thousand | 192.21 Thousand | -416.00 | 348.00 |
Investing Cash Flow | -1.26 Million | -769.68 Thousand | -1.89 Million | -1.46 Million | -6.61 Million | -1.36 Million |
Investments in PPE | -533.00 | -769.68 Thousand | 1.46 Million | -1.46 Million | -6.61 Million | -1.36 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.26 Million | -769.68 Thousand | -3.35 Million | - | - | - |
Financing Cash Flow | -672.01 Thousand | 3.21 Million | - | - | 1.85 Million | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | -672.01 Thousand | 3.21 Million | - | - | 1.85 Million | - |
Other Financing Activities | - | 3213.48 | - | - | 1855.78 | - |
Accounts receivables | 194.41 Thousand | -181.69 Thousand | -23.6 Thousand | -25.42 Thousand | 25.89 Thousand | 59.29 Thousand |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 371.46 Thousand | -634.95 Thousand | 340.67 Thousand | 44.54 Thousand | -998.28 Thousand | -178.46 Thousand |
Cash at beginning of period | 1.77 Million | 705.06 Thousand | 2.99 Million | 4.56 Million | 11.78 Million | 6.36 Million |
Cash at end of period | 265.83 Thousand | 1.77 Million | 705.06 Thousand | 2.99 Million | 4.56 Million | 4.56 Million |
Capital Expenditure | -533.00 | -769.68 Thousand | 1.46 Million | -1.46 Million | -6.61 Million | -1.36 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -1.51 Million | 1.07 Million | -2.28 Million | -1.57 Million | -7.21 Million | -1.79 Million |
Free Cash Flow | 421.39 Thousand | -2.14 Million | 1.06 Million | -1.57 Million | -9.07 Million | -1.79 Million |
NCX
FGR
0HF7
0ROG
INDP
VALIANTLAB